News & Publications

  • September 13, 2026||News||

    Professor James Chalmers, MBChB, PhD, FRCPE, FERS joins MCC Therapeutics Scientific Advisory Board

  • September 2, 2026||News||

    Presentation at the European Respiratory Society 2026

  • June 24, 2026||News||

    MCC Therapeutics, Inc. will present Phase 1 Clinical Results of MCCSA2 at the World Bronchiectasis Conference (WBC2026) in Hanover, Germany

  • June 5, 2026||News||

    MCC Therapeutics announces the Publication of its Scientists’ Paper in the Journal of Clinical Investigation